Advertisement

Topics

2017 Immunohematology and NAT Assays and Strategic Profiles of Leading Suppliers [Updated: 30032017] Prices from USD $3850

22:16 EDT 19 Jun 2017 | BioPortfolio Reports

This 280page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological knowhow, new products in Ramp;D, collaborative arrangements, and business strategies.nbsp;

Contains 280 pages and 6 tables

Original Article: 2017 Immunohematology and NAT Assays and Strategic Profiles of Leading Suppliers [Updated: 30032017] Prices from USD $3850

NEXT ARTICLE

More From BioPortfolio on "2017 Immunohematology and NAT Assays and Strategic Profiles of Leading Suppliers [Updated: 30032017] Prices from USD $3850"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...